The Maryland biotech company cut its 2022 sales outlook by about 50% and now expects to generate $2 billion to $2.3 billion in revenue this year.
from International: Top News And Analysis https://ift.tt/K0n8CWY
via IFTTT
Monday, August 8, 2022
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment